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Abstract
Synchronous gastric and colon cancer although reported from East Asia (China, Japan, Korea)
remain rare in other parts of the world. We present the case of a 50-year-old lady who
presented to the Hialeah Hospital, USA with an eight-month history of generalized abdominal
pain and upon investigation was found to have dual gastric and colonic malignancy. While the
incidence of gastric cancer has dropped drastically in the USA, colon cancer remains the third
most frequent cancer in both men and women. An estimated 2%-17% of oncological patients
may be affected by multiple primary malignancies and a high degree of clinical suspicion along
with appropriate diagnostic procedures is required for a definitive diagnosis.
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Introduction
The advent of sophisticated treatments in the field of cancer has led to increased survival times
among oncological patients. In 2014, more than 14 million Americans were living with a history
of cancer [1]. Patients with a history of cancer have a higher risk of developing multiple primary
neoplasms, i.e. more than one synchronous or metachronous tumor in the same or different
organs [2]. Widely reported in China, Japan, and Korea, we present the case study of a dual
primary malignancy involving stomach and colon from the USA, where such cases are relatively
uncommon.
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Case Presentation
A 50-year-old Hispanic lady presented with an eight-month history of dull, aching generalized
abdominal pain that worsened after meals, and was associated with nausea and reduced
appetite. Her stool had become softer than before, but there was no melena, and no
hematochezia. She had episodes of severe abdominal pain that disrupted her sleep every few
days. Review of systems revealed no weight loss. Her past medical history was significant for
hypertension, and past surgical history revealed the following four surgeries within the last 10
years: laparoscopic cholecystectomy, laparoscopic appendectomy, umbilical hernia repair, and
tubal ligation. She had been a lifelong nonsmoker and had never used alcohol. Her family
history revealed breast cancer in her mother and prostate cancer in her father. Her BMI was 38.
Physical examination was unremarkable. She underwent an upper gastrointestinal endoscopy
that showed a nonobstructing, nonbleeding cratered ulcer in the posterior wall of the gastric
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body. Biopsies were taken that revealed moderate-poorly differentiated adenocarcinoma. She
underwent positron-emission tomography (PET) scanning that showed increased uptake in two
regions: one in the medial gastric fundus (maximum SUV=14.2) and a second one near the
cecum (maximum SUV=18.6). Further the PET scan showed abnormal circumferential
thickening and pericolonic inflammatory changes involving the cecum, and numerous small
lymph nodes were noted in the right lower quadrant (largest lymph node=12 mm × 18 mm). One
week later, she underwent a colonoscopy that showed a fungating, partially obstructing,
nonbleeding, circumferential mass in the cecum. Biopsy showed a moderately differentiated
adenocarcinoma. The blood tests showed anemia (hemoglobin= 9.3) while all other tests were
unremarkable. Carcinoembryonic antigen (CEA) was 0.819 preoperatively. Based on the above
investigations it was decided that the patient has synchronous gastric and colon cancer and
that it is surgically resectable. A week later, she underwent an exploratory laparotomy, subtotal
gastrectomy with Roux-en-Y reconstruction and right colectomy with resection of terminal
ileum and ileocolostomy. The description of the procedure is as follows: in the supine position
on the OR table after being appropriately identified, induction of anesthesia, endotracheal tube
placement, area of the abdomen prepped, and draped in the standard sterile fashion. A midline
laparotomy incision was made from the xiphoid down to the umbilicus. That incision was
carried down from the skin and subcutaneous tissue until the abdomen was entered. An Alexis
wound retractor was placed for better exposure. Internal organs were grossly unremarkable.
Liver was inspected and noted to be free of any metastatic lesions. There were two malignant
appearing tumors, one in the body of the stomach and another one in the cecum. Both tumors
were easily identified by palpation although both were tattooed. We commenced the operation
with the gastric portion. We created an opening to the lesser sac and transected the branches of
the gastroduodenal artery along the greater curvature of the stomach. Then we excised the
branches of the right gastric artery supplying the lesser curvature. The tumor itself was located
in the body of the stomach that would save the junction between the proximal third and the
middle third of the stomach. So we fired a thoracoabdominal (TA-90) stapler with a few
centimeters margin into the proximal stomach. Then we proceeded by firing a gastrointestinal
anastomosis (GIA-75) stapler along the pylorus, transecting approximately two-thirds of the
stomach. The specimen was opened, and we decided to perform a Roux-en-Y reconstruction.
We went a couple of feet from the ligament of Treitz and a GIA stapler was used to separate the
jejunum. The jejunum was brought retrocolic all the way up into the proximal stomach. To
create an anastomosis we chose an end-to-end anastomosis (EEA-25) stapler. The anvil was
placed inside the proximal stomach creating an enterotomy that was approximated using
another fire on the GIA stapler. Then we proceeded by making an opening in the small bowl and
through that opening the EEA-25 stapler was then carefully introduced and it was opened. It
was then connected to the anvil previously placed in the proximal stomach under direct
visualization; the stapler was approximated and fired. The stapler was removed showing two
donuts indicating a patent anastomosis. The opening where the stapler entered the small bowel
was sealed using an Echelon stapler. Then we proceeded by curetting the anastomosis between
the two limbs of the jejunum. It was a side-to-side anastomosis using GIA and TA. Anastomosis
reinforced using 3-0 Vicryl sutures and noted to be widely patent with good coloration and
tension free. Anesthesia proceeded by advancing a nasogastric tube all the way down to the
anastomosis. Evicell was sprayed in the area to ensure complete hemostasis.
We then concentrated our attention on the right lower quadrant where the colon was visualized.
The tumor was in the right colon near the cecum. We started mobilizing the colon medial to the
white line of Toldt ensuring hemostasis. The proximal transverse colon was also mobilized by
transecting the hepatocolic ligaments. We proceeded then by firing a GIA in the terminal ileum;
another GIA was fired at the proximal transverse colon. Then using the Echelon stapler, series
of fires were used to transect the right mesocolon. We then proceeded by anastomosing the
terminal ileum and the transverse colon. It was side-to-side functional end-to-end anastomosis
using GIA and TA. Anastomosis reinforced using 3-0 Vicryl and it was noted to be widely patent
with good coloration and tension free.
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The abdomen was then irrigated with saline. The fluid was aspirated. No evidence of bleeding
or injury to intra-abdominal organs was noted. The Alexis retractor was removed. The fascia
was approximated using a running PDS, and the skin was approximated using staples followed
by sterile dressing applied on top. The patient tolerated the procedure well without any
complications. She was then transferred to recovery in stable condition. The counts were
correct ×2.
Both surgical specimens were sent to pathology. The surgical margins of both masses and the
21 excised nodes were tumor free. The distal gastrectomy specimen showed poorly
differentiated adenocarcinoma of the intestinal type (pT2aN0Mx) (Figure 1).
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FIGURE 1: Histopathology of distal stomach showing poorly
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differentiated adenocarcinoma of the intestinal type.

The right colectomy specimen showed moderately differentiated adenocarcinoma that was
invading the muscularis propria and extending into the subserosa (pT2aN0Mx) (Figures 2-3).
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FIGURE 2: Histopathology of colon showing moderately
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differentiated adenocarcinoma.

2019 Mederos et al. Cureus 11(1): e3892. DOI 10.7759/cureus.3892

7 of 10

FIGURE 3: Histopathology slide of colon showing cancer cells
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invading muscularis propria and extending into the serosa.

Postoperatively the patient remained well (she was ambulating, tolerating oral diet, and pain
was under control) and was discharged on the fourth postoperative day. She followed up in
clinic up to two months after the surgery. She was about to begin chemotherapy. She missed her
latest clinic appointment.

Discussion
We report a case of concurrent gastric and colon cancer in a middle-aged lady from the
USA. Colon and gastric cancer are two of the five most common malignancies worldwide, along
with lung, breast, and prostate cancer. While, three East Asian (China, Japan, Korea) countries
account for more than 60% of the global burden of gastric cancer, the incidence of gastric
cancer in the USA has fallen by 80% since 1950 [3]. Colorectal cancer, however, is the second
leading cause of cancer-related deaths in the USA and third most common cancer in both
sexes [4].
In 1932, Warren and Gates proposed the first definition of multiple primary neoplasms stating
that: (a) each tumor must be malignant by histology; (b) each tumor must be anatomically
distinct; and (c) the second tumor should not be a recurrence or metastasis of the first one. A
synchronous cancer is defined as any cancer that occurs within six months of the first one
whereas a metachronous cancer is one that occurs at least six months after the first cancer [2].
Metachronous tumors are more common than synchronous tumors. Second primary tumors are
more common than third or fourth primary tumors [5]. In the literature the incidence of
multiple primary neoplasms ranges from 2% to 17% [1].
With advances in diagnostic modalities, there has been a surge in the incidence of multiple
primary neoplasms. Patients with gastric cancer, for instance, are at an increased risk of
developing a secondary neoplasm [2]. Further, the advent of novel chemotherapeutic drugs has
led to increased survival rates among cancer patients. Cancer survivors have a 20% greater risk
for developing a second primary malignancy than the general population [5].
Genetic, environmental, and lifestyle factors act synergistically in the pathogenesis of multiple
primary neoplasms. The CHEK2 gene, for instance, has been implicated in concurrent stomach
and colon cancer among others such as breast, prostate, thyroid, and kidney. Other examples of
gene mutations involved in the pathogenesis of multiple primary neoplasms include the cellcycle regulator p53 (Li Fraumeni syndrome) and the DNA repair protein BRCA (breast, ovary,
and pancreatic cancer). Lifestyle influences such as the use of alcohol, tobacco, and
nitrosamines can play a role in cancer pathogenesis as they are known to contain
carcinogens [1]. Patients with history of multiple cancers should undergo a complete evaluation
including family history, genetic counseling, and cancer screening, to estimate their risk of
developing another neoplasm. Women with colonic cancer who have a family history of
endometrial or ovarian malignancy, may have Lynch syndrome. Lynch syndrome is caused by an
autosomal dominant defect in the mismatch repair proteins leading to microsatellite instability
and can cause colon cancer despite the absence of polypoidal growth [1]. The recommended
screening modalities for colon cancer and gastric cancer are, respectively, colonoscopy and
esophagogastroduodenoscopy. The caveat in diagnosing multiple primary neoplasms is that
one cancer can be mistaken for a metastasis of the other one. Hence, it is necessary to biopsy
all neoplasms to establish the diagnosis [6].
Family members of patients must be screened. According to the American Cancer Society
guidelines for colorectal cancer, for patients younger than 60 at the time of diagnosis (as is the
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case with our patient) first-degree relatives must begin screening colonoscopy either at age 40
or 10 years before the youngest case in the family was diagnosed. Screening colonoscopy is to
be repeated every 5 years [7]. In contrast, routine endoscopic screening for gastric cancer is not
recommended because there is evidence that screening in low incidence regions, such as the
USA does not lead to a reduction in mortality [8]. Screening endoscopy for gastric cancer is
recommended only in high-risk areas such as Japan. Yaghoobi et al. recommend that even in
low-risk regions, people who are at high-risk for gastric cancer should be screened and treated
for Helicobacter pylori infection [9].

Conclusions
The presence of multiple neoplasms must be considered among all oncological patients who
have more than one tumor. Multiple primary neoplasms pose a diagnostic challenge as they can
be mistaken for metastasis. A multitude of diagnostic tests, such as endoscopy and radiological
imaging can be employed to screen patients and family members, whereas a definitive diagnosis
can be established only after biopsy of any suspicious lesions. The treatment should be planned
such that it targets all the primary neoplasms.
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